The development of COVID-19 vaccines is progressing very quickly for several reasons, including: advances in science and technology; international collaboration among scientists, health professionals, researchers, industry and governments; and, increased dedicated funding. However, any vaccines used in Canada must be approved by Health Canada through its rigorous regulatory process. The same review process is applied to all vaccines.

COVID-19 vaccines will only be used in Newfoundland and Labrador if they are approved by Health Canada, and the evidence shows that they are safe, effective, of good quality and demonstrates that the benefits of using it outweighs the risks. For more information on Health Canada’s review process for COVID-19 vaccines, please see the Government of Canada’s website.

Vaccines are constantly monitored after they are approved for safety and effectiveness. Pharmaceutical companies, health care providers and Health Canada are involved in this monitoring process. Health Canada and the Public Health Agency of Canada will take action if there are any problems with a vaccine. Vaccines are monitored in this way for as long as they are in use.